Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Common Equity (2016 - 2025)

Innospec's Common Equity history spans 16 years, with the latest figure at $1.3 billion for Q4 2025.

  • For Q4 2025, Common Equity rose 9.49% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, up 9.49%, while the annual FY2025 figure was $1.3 billion, 9.49% up from the prior year.
  • Common Equity for Q4 2025 was $1.3 billion at Innospec, up from $1.3 billion in the prior quarter.
  • Across five years, Common Equity topped out at $1.3 billion in Q4 2025 and bottomed at $959.1 million in Q1 2021.
  • The 5-year median for Common Equity is $1.1 billion (2023), against an average of $1.1 billion.
  • The largest YoY upside for Common Equity was 11.45% in 2022 against a maximum downside of 0.72% in 2022.
  • A 5-year view of Common Equity shows it stood at $1.0 billion in 2021, then rose by 0.72% to $1.0 billion in 2022, then grew by 10.5% to $1.1 billion in 2023, then rose by 5.36% to $1.2 billion in 2024, then grew by 9.49% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for IOSP's Common Equity are $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025).